Related Experiment Video

Updated: May 24, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma

Shannon L Russell1, Matthew J Gold, Martin Hartmann

  • 1Department of Microbiology & Immunology, University of British Columbia, Vancouver, British Columbia, Canada.

EMBO Reports
|March 17, 2012
PubMed

Insights

Neonatal exposure to vancomycin antibiotic altered gut microbiota, increasing allergic asthma severity in mice. This supports the hygiene hypothesis, linking early-life microbial changes to immune disease development.

Area of Science:

  • Microbiology
  • Immunology
  • Environmental Health

Background:

  • Allergic asthma prevalence is rising globally, suggesting environmental factors play a key role.
  • The gut microbiota's influence on immune system development and disease susceptibility is an area of growing interest.

Purpose of the Study:

  • To investigate the impact of early-life antibiotic exposure on gut microbiota composition and its subsequent effect on experimental allergic asthma in mice.

Main Methods:

  • Neonatal mice were treated with streptomycin or vancomycin, common antibiotics, to assess changes in gut flora.
  • Disease severity was evaluated following allergic asthma induction.
  • Antibiotic effects were compared between neonatal and adult treatment groups.

Main Results:

  • Vancomycin significantly reduced microbial diversity and altered gut bacterial composition, leading to enhanced allergic asthma severity in neonatal mice.
  • Streptomycin had minimal impact on microbiota and asthma outcomes.
  • Antibiotic administration to adult mice did not significantly affect asthma susceptibility.

Conclusions:

  • Early-life gut microbiota dysbiosis, induced by specific antibiotics like vancomycin, increases susceptibility to experimental allergic asthma.
  • Findings support the 'hygiene hypothesis' by highlighting a critical neonatal window for microbiota-driven immune programming.
  • Targeted interventions during early life may be crucial for preventing allergic diseases.

More Related Videos

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: